| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.33 | 0.05 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |